Meningococcal serogroup B vaccines: will they live up to expectations?
- PMID: 21604975
- PMCID: PMC3985070
- DOI: 10.1586/erv.11.41
Meningococcal serogroup B vaccines: will they live up to expectations?
References
-
- Wong SH, Lennon DR, Jackson CM, et al. Immunogenicity and tolerability in infants of a New Zealand epidemic strain meningococcal B outer membrane vesicle vaccine. Pediatr. Infect. Dis. J. 2009;28:385–390. - PubMed
-
- Findlow J, Borrow R, Snape MD, et al. Multicenter, open-label, randomized Phase II controlled trial of an investigational recombinant meningococcal serogroup B vaccine with and without outer membrane vesicles, administered in infancy. Clin. Infect. Dis. 2010;51:1127–1137. - PubMed
-
- Bambini S, Muzzi A, Olcen P, Rappuoli R, Pizza M, Comanducci M. Distribution and genetic variability of three vaccine components in a panel of strains representative of the diversity of serogroup B meningococcus. Vaccine. 2009;27:2794–2803. - PubMed
Website
-
- Neisseria factor H binding protein sequence typing. http://pubmlst.org/neisseria/fHbp/
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical